Document Detail


Utility of Intra-Aortic Balloon Pump Support for Ventricular Septal Rupture and Acute Mitral Regurgitation Complicating Acute Myocardial Infarction.
MedLine Citation:
PMID:  24035169     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Clinical data on optimal management of mechanical complications of myocardial infarction are lacking. We retrospectively evaluated the effect of intra-aortic balloon pump (IABP) on 30-day survival in patients with postinfarction ventricular septal rupture (VSR, n = 55) or acute mitral regurgitation (MR, n = 26) who developed either cardiogenic shock (n = 46) or severe hemodynamic instability that did not fulfill the criteria of shock (n = 35). IABP was inserted in 83% of the patients with shock and 57% of those without shock. Thirty-five (76%) patients with shock and all unstable patients survived until surgical repair, which was performed within a median (interquartile range) of 1 (1 to 2) and 9 (2 to 18) days from the onset of the complication (p <0.001). All patients who did not undergo the operation died within 3 days. Although MR presented more acutely, the patients' outcomes were similar to those with VSR. IABP support reduced 30-day mortality in the patients with shock (61% vs 100%, p = 0.04) but not in the patients without shock (20% vs 27%, p = 0.7). The benefit of IABP support in the shock cohort was driven mainly by reduction of preoperative mortality (11% vs 88%, p <0.001). Early progression of cardiogenic shock and unperformed surgery were the only independent predictors of 30-day mortality (hazard ratio 3.4, 95% confidence interval 1.5 to 8 and hazard ratio 5.1, 95% confidence interval 2.2 to 11, respectively; p = 0.004 and p <0.001, respectively). In conclusion, we suggest that all patients with postinfarction VSR or acute MR with signs of cardiogenic shock should immediately receive IABP as a bridge to emergent surgical repair. In contrast, hemodynamically unstable patients without shock may be first stabilized by medical therapy, without additional benefit of IABP, before they undergo cardiac surgery.
Authors:
Jiri Kettner; Marek Sramko; Martin Holek; Jan Pirk; Josef Kautzner
Related Documents :
18053159 - Native cardiac reserve predicts survival in acute post infarction heart failure in mice.
2060839 - The evolution of oxidative stress indicators in the course of myocardial ischemia.
19118249 - Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome pati...
15819299 - Antecedent hypertension interacts with adverse ventricular remodeling after myocardial ...
2060109 - Reversible and irreversible elongation of ischemic, infarcted, and healed myocardium in...
16769909 - Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survi...
11514489 - Quantitative contrast echocardiographic assessment of collateral derived myocardial per...
8836759 - Absence of the inferior vena cava in a patient with omphalocele: two-dimensional echoca...
1674899 - Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-12
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-9-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Affiliation:
Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: jiri.kettner@ikem.cz.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle ...
Next Document:  Effectiveness and Safety of Spironolactone for Systolic Heart Failure.